IBRX — Immunitybio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapMomentum Trap

Annual balance sheet for Immunitybio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	317	107	266	150	243
Net Total Accounts Receivable
Net Total Receivables	1.33	1.89	3.17	2.65	42.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	334	141	294	185	315
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	119	190	183	170	147
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	469	362	504	383	502
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	369	501	58.3	54.9	61.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	711	810	1,091	872	1,002
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-242	-447	-587	-489	-500
Total Liabilities & Shareholders' Equity	469	362	504	383	502
Total Common Shares Outstanding